Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Current cancer drug targets"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Yao%2C+Hang-Ping%22&type=Person&filter%5B%5D=journalStr%3A%22Current+cancer+drug+targets%22
/vufind/Search/Results?lookfor=%22Yao%2C+Hang-Ping%22&type=Person&filter%5B%5D=journalStr%3A%22Current+cancer+drug+targets%22
Search /vufind/Search2/Results?lookfor=%22Yao%2C+Hang-Ping%22&type=Person&filter%5B%5D=journalStr%3A%22Current+cancer+drug+targets%22
PubPharm (6)
1
RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells
enthalten in:
Current cancer drug targets
| 2023
von
Suthe, S.
|
Yao, H.
|
Weng, T.
| +1
Wird geladen...
2
Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase
enthalten in:
Current cancer drug targets
| 2022
von
Hudson, R.
|
Yao, H.
|
Suthe, S.
| +2
Wird geladen...
3
Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase
enthalten in:
Current cancer drug targets
| 2022
von
Hudson, R.
|
Yao, H.
|
Suthe, S.
| +2
Wird geladen...
4
Oncogenic variant RON160 expression in breast cancer and its potential as a therapeutic target by small molecule tyrosine kinase inhibitor
enthalten in:
Current cancer drug targets
| 2013
von
Yao, H.
|
Zhuang, C.
|
Zhou, Y.
| +3
Wird geladen...
5
Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor
enthalten in:
Current cancer drug targets
| 2013
von
Yao, H.
|
Zhuang, C.
|
Zhou, Y.
| +3
Wird geladen...
6
Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor
enthalten in:
Current cancer drug targets
| 2013
von
Yao, H.
|
Zhuang, C.
|
Zhou, Y.
| +3
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Current cancer drug targets
Medienart
6
Aufsätze
5
E-Artikel
5
E-Ressourcen
1
Gedruckte Aufsätze
Zeitschriftentitel
Current cancer drug targets
Thema
3
Journal Article
3
Research Support, Non-U.S. Gov't
2
EC 2.7.10.1
2
Immunoconjugates
2
antibody-drug conjugate
2
therapeutic efficacy
1
130288-24-3
1
5-((2,6-dichlorobenzyl)sulfonyl)-3-((3,5-dimeth...
1
Antibodies, Monoclonal
1
Antineoplastic Agents
1
Duocarmycins
1
Indoles
1
MET receptor tyrosine kinase
1
Neoplasm Proteins
1
Protein Kinase Inhibitors
1
Proto-Oncogene Proteins c-met
1
RON protein
1
RON receptor tyrosine kinase
1
Receptor Protein-Tyrosine Kinases
1
Research Support, N.I.H., Extramural
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2020-
3
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5
Englisch
Haven't found what you're looking for?
Wird geladen...